.jpg)
.jpg)
01 Apr, 2020
Roche Pharma Acquires Ignyta for $1.7 billion
Roche Holdings entered into a definitive agreement with Ignyta Inc. (NASDAQ: RXDX) to acquire the biotech company specialized in the oncology field. Under the agreement, Roche agreed to purchase Ignyta at a price of $27.00 per share in cash. I..
Merck Acquires Rigontec for $550 Million
Merck & Co. Inc. (NYSE: MRK) announced today its acquisition of German biotech start-up, Rigontec for approximately €464 million or $550 million to further advance studies and research in cancer treatment development.Merck agreed to pay &eu..
Novartis Immunocellular Therapy Approved by FDA
Novartis AG (NYSE: NVS) announced Wednesday that the US Food and Drug Administration (FDA) has approved Kymriah (TM)(tisagenlecleucel) suspension for intravenous infusion, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment..
Clovis Oncology Inc. (NASDAQ: CLVS)Shares Spiked After Positive Phase 3 Data
Clovis Oncology Inc. (NASDAQ: CLVS) is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. The company’s shares jumped ab..
@Newsletter
Sign Up for Weekly UpdatesOpt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!
No articles found.
.jpg){kind=small}
All rights reserved.
No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).